Related Experiment Videos
Differential brain area vulnerability to long-term subcortical excitotoxic lesions
N Mahy1, G Bendahan, M L Boatell
1Unit of Biochemistry, School of Medicine, University of Barcelona, Spain.
Neuroscience
|March 1, 1995
Summary
Excitotoxic lesions in the basal forebrain cause long-term neurodegeneration and calcium deposits, particularly in the globus pallidus. Glutamate receptor activation influences neuronal damage and cholinergic deficits.
Area of Science:
- Neuroscience
- Neurotoxicology
Background:
- Excitotoxicity, a process involving excessive glutamate stimulation, can lead to neuronal damage.
- The basal forebrain plays a crucial role in cholinergic neurotransmission and cognitive functions.
Purpose of the Study:
- To investigate the long-term neurodegenerative effects of excitatory amino acid microinjections in the basal forebrain.
- To examine the correlation between excitotoxicity, calcium imbalance, and cholinergic deficits.
Main Methods:
- Microinjections of ibotenic acid (NMDA receptor agonist) and quisqualic acid (non-NMDA receptor agonist) into the medial septal nucleus and ventral globus pallidus.
- Assessment of neuronal death, calcium deposits, and cholinergic markers (choline acetyltransferase, acetylcholine esterase) at various time points post-lesion.
Main Results:
- Long-term nerve cell death and calcium deposits were observed in the globus pallidus, more pronounced with ibotenic acid.
- Glutamate receptor subtypes (NMDA, AMPA, metabotropic) are implicated in the calcium imbalance.
- Quisqualic acid lesions caused significant cholinergic cell body and nerve terminal loss, while ibotenic acid lesions resulted in lower cholinergic deficits.
Conclusions:
- Glutamate excitotoxicity can induce long-term neurodegenerative processes.
- Distinct patterns of neuronal damage, including intracellular calcium deposits, occur following excitotoxic lesions in the basal forebrain.
- The extent of neuronal damage and calcium imbalance does not directly correlate with the observed cholinergic deficits.